ACS Chemical Biology · 2021 · 19 citations · 30 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoverySignal TransductionAllosteric ModulationAllosteric RegulationDrug-receptor InteractionsG Protein-coupled Receptor SignalingLigand BindingReceptor-ligand InteractionsAllosteric Modulation Of G Protein-coupled ReceptorsCryptic Pocket DiscoveryG-protein-coupled ReceptorsGlp-1 Receptor PharmacologyGlucagon-like Peptide 1 Receptor AgonismGlucagon-like PeptidesPositive Allosteric ModulatorsReceptor Allosteric Sites
The glucagon-like peptide-1 receptor (GLP-1R) is a well-established drug target for the treatment of type II diabetes. The development of small-molecule positive allosteric modulators (PAMs) of GLP-1R is a promising therapeutic strategy. Here, we report the discovery and characterization of PAMs with distinct chemotypes, binding to a cryptic pocket formed by the cytoplasmic half of TM3, TM5, and TM6. Molecular dynamic simulations and mutagenesis studies indicate that the PAM enlarges the orthosteric pocket to facilitate GLP-1 binding. Further signaling assays characterized their probe-dependent signaling profiles. Our findings provide mechanistic insights into fine-tuning GLP-1R via this allosteric pocket and open up new avenues to design small-molecule drugs for class B G-protein-coupled receptors.
30
The Influence of GLP-1 on Glucose-Stimulated Insulin Secretion
Lise Kjems, Jens J. Holst, Aage Vølund et al. · Diabetes · 2003 · 580 citations · Full text
Structure of class B GPCR corticotropin-releasing factor receptor 1
Kaspar Hollenstein, James Kean, Andrea Bortolato et al. · Nature · 2013 · 414 citations
Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulators
Gaojie Song, Dehua Yang, Yuxia Wang et al. · Nature · 2017 · 244 citations